RFA-CA-21-005 - Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Innovative Molecular Analysis Technologies for Low-Resource Settings Globally | NOT-CA-21-025 | NCI | Jan 4, 2021 | Sep 30, 2021 | R21 |
For technical issues E-mail OER Webmaster